State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Dept. of Oral and Maxillofacial Surgery, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
Hua Xi Kou Qiang Yi Xue Za Zhi. 2021 Jun 1;39(3):245-254. doi: 10.7518/hxkq.2021.03.001.
The morbidity rate of medication-related osteonecrosis of the jaws (MRONJ) increased rapidly in recent years. Thusfar, the mechanism of MRONJ has no consensus. The possible mechanisms may include bone remodeling inhibition theory, angiogenesis inhibition theory, oral microorganism infection theory, immunosuppression theory, cytotoxicity-targeted oral epithelial cells, microcrack formation of maxillary or mandibular bone, and single nucleotide polymorphism. However, the efficacy of prevention and treatment based on a single mechanism is not ideal. Routine oral examination before MRONJ-related drug treatment, treatment of related dental diseases, and regular oral follow-up during drug treatment are of great significance for the prevention of MRONJ. During the treatment of MRONJ, the stage of MRONJ must be determined accurately, treatment must be standardized in accordance with the guidelines, and personalized adjustments must be made considering the specific conditions of patients. This review aimed to combine the latest research and guidelines for MRONJ and the experiences on the treatment of MRONJ in the Maxillofacial Surgery Department of West China Hospital of Stomatology, Sichuan University, and discuss the strategies to improve the clinical process.
近年来,药物相关性颌骨坏死(MRONJ)的发病率迅速上升。迄今为止,MRONJ 的发病机制尚未达成共识。可能的机制包括骨重塑抑制理论、血管生成抑制理论、口腔微生物感染理论、免疫抑制理论、细胞毒性靶向口腔上皮细胞、上颌或下颌骨微裂纹形成和单核苷酸多态性。然而,基于单一机制的预防和治疗效果并不理想。在 MRONJ 相关药物治疗前进行常规口腔检查、治疗相关口腔疾病,以及在药物治疗期间定期进行口腔随访,对预防 MRONJ 具有重要意义。在治疗 MRONJ 时,必须准确确定 MRONJ 的阶段,必须根据指南进行规范化治疗,并根据患者的具体情况进行个性化调整。本综述旨在结合 MRONJ 的最新研究和指南,以及四川大学华西口腔医院颌面外科治疗 MRONJ 的经验,讨论改善临床流程的策略。